Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4542792 | 5706635 | F | 4542792-7 | 20041101 | 20041208 | 20041231 | EXP | PHBS2004JP16522 | NOVARTIS PHARMACEUTICALS CORP. | 27 | YR | F | Y | 54 | KG | 20041229 | MD |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
4542792 | 1005547059 | PS | VOLTAREN | 1 | ORAL | 75 MG/DAY | |||||
4542792 | 1005547060 | SS | TERNELIN | 2 | ORAL | 3 MG/DAY | |||||
4542792 | 1005547061 | SS | MUCOSTA | 2 | ORAL | 300 MG/DAY | |||||
4542792 | 1005547062 | C | MECOBALAMIN | 2 | ORAL | 1000 UG/DAY |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
4542792 | 1005547059 | INTERVERTEBRAL DISC PROTRUSION |
4542792 | 1005547060 | INTERVERTEBRAL DISC PROTRUSION |
4542792 | 1005547061 | INTERVERTEBRAL DISC PROTRUSION |
Outcome of event
Event ID | OUTC COD |
---|---|
4542792 | HO |
Reactions reported
Event ID | PT |
---|---|
4542792 | ALANINE AMINOTRANSFERASE INCREASED |
4542792 | ASPARTATE AMINOTRANSFERASE INCREASED |
4542792 | BACK PAIN |
4542792 | CONDITION AGGRAVATED |
4542792 | GAMMA-GLUTAMYLTRANSFERASE INCREASED |
4542792 | LIVER DISORDER |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | RPSR COD |
---|---|
4542792 | HP |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
4542792 | 1005547059 | 20041108 | 20041207 | 43200 | MIN |
4542792 | 1005547060 | 20041108 | 20041207 | 43200 | MIN |
4542792 | 1005547061 | 20041108 | 20041207 | 43200 | MIN |
4542792 | 1005547062 | 20041115 |